HI
ELV icon

HBK Investments’s Elevance Health ELV Stock Holding History

HBK Investments’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-53,400
Closed -$28.9M – 178
2024
Q2 		$28.9M Sell
53,400
-9,800
-16% -$5.18M 0.13% 38
2024
Q1 		$32.8M Buy
63,200
+58,000
+1,115% +$28.8M 0.14% 27
2023
Q4 		$2.45M Buy
+5,200
New +$2.4M 0.01% 154

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

HBK Investments's ELV Position: Q3 2024 in Review

HBK Investments sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 14,921 shares — an estimated $8.09M sold.

HBK Investments first reported a position in ELV in Q2 2013 and held it in 15 quarters. The position peaked at $12.4M in Q3 2017. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • HBK Investments reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • HBK Investments sold 14,921 Elevance Health shares in Q3 2024, an estimated $8.09M.
  • HBK Investments first reported a position in Elevance Health in Q2 2013 and held it in 15 quarters.
  • HBK Investments's Elevance Health position peaked at $12.4M in Q3 2017.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on HBK Investments's 13F filing for Q3 2024, filed 14 Nov 2024.